Pros and cons of corticosteroid therapy for COVID-19 patients

In December 2019, an outbreak of severe pneumonia was reported in Wuhan, China. Later described as COVID-19 (coronavirus disease 2019), this infection caused by a virus from the Coronaviridae family (SARS-CoV-2) has spread globally. Effective therapies for this new disease are urgently needed. In th...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Respir Physiol Neurobiol
Main Authors: Mattos-Silva, Paula, Felix, Nathane Santanna, Silva, Pedro Leme, Robba, Chiara, Battaglini, Denise, Pelosi, Paolo, Rocco, Patricia Rieken Macedo, Cruz, Fernanda Ferreira
Formato: Artigo
Idioma:Inglês
Publicado: Elsevier B.V. 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7351052/
https://ncbi.nlm.nih.gov/pubmed/32659271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.resp.2020.103492
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares